Cidara Therapeutics Inc (NASDAQ:CDTX) Reported Basic Consolidated EPS Of $-3.2453

0

For the period ended 2015-12-31, Cidara Therapeutics Inc (NASDAQ:CDTX) reported $-3.2453 as the annual basic consolidated EPS. On quarterly basis, $-3.2453 was captured as the basic consolidated EPS reading for the quarter ended 2015-12-31.

EPS from continuing operations

For the annual period ended 2015-12-31 and in line with the basic EPS from continuing operations Cidara Therapeutics Inc (NASDAQ:CDTX) reported $-3.2453. For the three-month period ended 2015-12-31, quarterly basis EPS from continuing operations stood at $-3.2453.

EPS contribution from parent

Basic EPS received by Cidara Therapeutics Inc (NASDAQ:CDTX) from its parent company was $-3.2453 for the annual period ended 2015-12-31. For the period ended 2015-12-31, the quarterly basis the basic EPS contribution from the parent company was $-3.2453.

Basic net EPS

Cidara Therapeutics Inc (NASDAQ:CDTX) reported basic net EPS of $-3.25 for the annual period ended 2015-12-31. The company’s basic net EPS on a quarterly basis stood at $-3.25 for the three-month period ended 2015-12-31.

Consolidated diluted EPS

The period ended 2015-12-31 had an annual consolidated diluted EPS reading of $-3.2453. Consolidated diluted EPS for the quarter ended 2015-12-31 was $-3.2453.

b>Basic diluted EPS

For the period ended 2015-12-31 diluted EPS reading from continuing operation on annual basis was $-3.2453. However, $-3.2453 was registered as the Diluted EPS from continuing operations for the quarter ended 2015-12-31.

Net diluted EPS

For the annual period ended 2015-12-31, $-3.25 was the Net diluted EPS reading. But the quarterly period that ended 2015-12-31, net diluted EPS was $-3.25.

Diluted EPS from parent

Cidara Therapeutics Inc (NASDAQ:CDTX) received diluted EPS of $-3.2453 from the parent company which was for the annual period ended 2015-12-31. However, on quarterly basis, $-3.2453 was the diluted EPS contribution from the parent for the quarter ended 2015-12-31. The net basic EPS reading of $-3.25 was posted by Cidara Therapeutics Inc (NASDAQ:CDTX) which was representing the annual period ended 2015-12-31. Basic net EPS of $-3.25 was for the quarter ended 2015-12-31.

For the annual period ended 2015-12-31, Net diluted EPS was $-3.25 for the annual period ended 2015-12-31. There was also a report by the company of $-3.25 being the net diluted EPS reading for the quarter ended 2015-12-31.

While the shares for the quarter ended 2015-12-31 were at 13.872, the period ended 2015-12-31 is 13.872 being the annual average basic shares outstanding.

For the fiscal year ended is 2015-12-31 while 13.872 represents the quarter ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 10 times, 1 visits today)